VIRTUS INVESTMENT ADVISERS INC
Q3 2026 Form 13-F

HARTFORD, CONNECTICUT
CIK 0000019481 · CRD 106982 · SEC-registered investment adviser
Holdings reported by NFJ INVESTMENT GROUP LLC since Q2 2021 , Virtus ETF Advisers LLC since Q1 2025 , DUFF & PHELPS INVESTMENT MANAGEMENT CO since Q1 2016 and 7 more
$452.8M Reported Value Total

VIRTUS INVESTMENT ADVISERS, LLC reports 106 total accounts under management (AUM). There are 106 discretionary accounts valued at $51,744,428,475, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Source: Form ADV filed 2026-06-30
Reported value
$452.8M
Quarter over quarter
-2.8%
Holdings
458
Top-10 concentration
9.6%

Holdings reported by

Key People

Form ADV owners & control persons
Daphne Tippens Chisolm
VICE PRESIDENT, SENIOR COUNSEL AND ASSISTANT SECRETARY
Jennifer Seymour Fromm
VICE PRESIDENT, SENIOR COUNSEL AND ASSISTANT SECRETARY
David George Hanley
TREASURER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 12, 2026
Form 13F-HR
Reported value $452.8M
Positions 458
Change in reported value +5.5%
New positions 45
Exited positions 50
Position turnover 18.7%
Top-10 concentration 9.6%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 12, 2026
458 $452.8M
Q2 2026 13F
Filed Aug 11, 2026
463 $429.2M
Q1 2026 13F
Filed May 14, 2026
450 $362.5M
Q4 2025 13F
Filed Feb 17, 2026
461 $367.9M
Q3 2025 13F
Filed Nov 14, 2025
440 $349.3M
Q2 2025 13F
Filed Aug 13, 2025
439 $295.8M
Q1 2025 13F
Filed May 15, 2025
470 $367.8M
Q4 2024 13F
Filed Feb 14, 2025
293 $127.6M
Q3 2024 13F
Filed Nov 14, 2024
269 $127.1M
Q2 2024 13F
Filed Aug 14, 2024
253 $118.2M
Q1 2024 13F
Filed May 16, 2024
264 $139.9M
Q4 2023 13F
Filed Feb 15, 2024
346 $133.5M
Q3 2023 13F
Filed Nov 8, 2023
242 $147.0M
Q2 2023 13F
Filed Aug 14, 2023
259 $147.2M
Q1 2023 13F
Filed May 15, 2023
273 $142.8M
Q4 2022 13F
Filed Feb 14, 2023
320 $150.0M
Q3 2022 13F
Filed Nov 14, 2022
375 $217.6M

30 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 MRNA MODERNA INC $6.5M 1.44%
2 IOVA IOVANCE BIOTHERAPEUTICS INC $6.1M 1.35%
3 REGN REGENERON PHARMACEUTICALS $4.2M 0.92%
4 GILD GILEAD SCIENCES INC $4.1M 0.91%
5 AMGN AMGEN INC $4.0M 0.89%
6 VRTX VERTEX PHARMACEUTICALS INC $4.0M 0.89%
7 OMER OMEROS CORP $3.7M 0.81%
8 INCY INCYTE CORP $3.7M 0.81%
9 BMRN BIOMARIN PHARMACEUTICAL INC $3.6M 0.81%
10 VSTM VERASTEM INC $3.3M 0.73%
11 PGEN PRECIGEN INC $3.2M 0.72%
12 OKTA OKTA INC $2.9M 0.65%
13 MRVL MARVELL TECHNOLOGY INC $2.9M 0.64%
14 HALO HALOZYME THERAPEUTICS INC $2.7M 0.59%
15 HPE HEWLETT PACKARD ENTERPRISE C $2.7M 0.59%
16 ZLAB ZAI LAB LTD $2.6M 0.57%
17 AMD ADVANCED MICRO DEVICES INC $2.6M 0.57%
18 RIGL RIGEL PHARMACEUTICALS INC $2.5M 0.55%
19 MU MICRON TECHNOLOGY INC $2.5M 0.55%
20 KNSA KINIKSA PHARMACEUTICALS INTL $2.4M 0.54%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Similar Managers

Finding Similar Managers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings